![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25599-25607, September 3, 1999
From the We reported previously that long-chain fatty
acids are potent inhibitors of mammalian DNA polymerase We reported previously that long-chain fatty acids strongly
inhibited the activities of mammalian DNA polymerase Pol The crystal and NMR structures of pol Sample Preparation--
The N-terminal 8-kDa fragment of rat DNA
pol Photoaffinity Cross-linking of Proteolytic Fragments of Pol Circular Dichroism Spectroscopy--
For CD analysis, 6.25 µM (50 µg/ml) purified 8-kDa domain fragment of pol NMR Experiments--
NMR spectra were measured at 750 MHz on a
Varian Unity-Plus 750 spectrometer. 1H-15N HMQC
spectra were recorded at a temperature of 30 °C. Each spectrum size
was 1024 complex points in the t2 dimension and 96 complex points in
t1. The data were zero filled in both dimensions, and a shifted
sine-bell was applied as a window function for resolution enhancement.
A total of 32 scans per FID was accumulated, leading to a measuring
time of 90 min per HMQC spectrum.
The in vitro relationship between mammalian DNA
polymerases and fatty acids has been investigated (2, 3). As
described in the Introduction, longer chain fatty acids (over 18 carbons) strongly inhibited DNA polymerase activities in
vitro. Fatty acids in which they are of the
trans-configuration have much weaker inhibitory effects on
especially pol The effects of fatty acid were analyzed using proteolytic methods. Rat
pol Analysis of the Binding between Fatty Acids and Fragments of 8 and
31 kDa of Pol
LA and NA interfered with complex formation of the 8-kDa fragment and
ssDNA template (Fig. 1,B and C).
pT14D at a concentration of 0.8 pmol was added to 18 pmol
of the 8-kDa fragment along with various concentrations of LA (Fig.
1B) or NA (Fig. 1C). The I/E (inhibitor/enzyme) ratios in the presence of 0, 1.8, 3.6, and 7.2 µM fatty acids (LA is Fig. 1B, NA is Fig.
1C) were 0, 0.25, 0.5, and 1, respectively. NA interfered
with binding of the DNA to the 8-kDa fragment, and at an I/E
ratio of 1, the interference became nearly complete (Fig.
1C). We, therefore, concluded that one molecule of fatty
acids competes with oligonucleotide, i.e. dT14D,
suggesting that a fatty acid molecule interferes with the binding of
template DNA to one molecule of the 8-kDa domain fragment. Similar
results were obtained using LA instead of NA (Fig. 1B). LA
also interfered with DNA binding to the fragment, but the interference was not complete at an I/E ratio of 1. Thus, the
C24 fatty acid, NA, showed stronger interference than the
C18 fatty acid, LA, at the I/E ratio of 1. This
may explain the observation that the inhibition of pol
To explain why the minimum inhibitory dose of the longer chain fatty
acid was much lower than that of short chain species, the dissociation
constants (KD) between each of the fatty acids and
the domain fragment were also analyzed as described in the later part
of this report (Fig. 3). To investigate the binding mode including
KD in detail, NMR structures of the N-terminal 8-kDa
domain with or without the fatty acids were determined.
CD Spectra of 8-kDa Domain and Mixture of 8-kDa Domain and Fatty
Acids--
The CD spectra of complexes of the 8-kDa domain fragment
and the fatty acids were very similar to the CD spectrum of the 8-kDa domain fragment alone (Fig. 2). The
comparable maximal negative ellipticities at 208 and 220 nm indicated
that the overall helical structure in the mixture of the 8-kDa domain,
and the fatty acids were similar to that of the 8-kDa domain fragment
alone (Fig. 2). The spectra of the protein-LA complex and the
protein-NA complex were similar to each other, but the maximal negative
ellipticity of 208 nm and the maximal positive ellipticity of 235-260
nm of the protein-NA complex were higher than those of the protein LA complex (Fig. 2). The unchanged ratio of the maximal negative ellipticity at 222 nm versus 208 nm in the mixture of the
8-kDa domain fragment and the fatty acids suggested no increase in
helical structure in comparison with the 8-kDa domain fragment alone. On the basis of these results, we concluded that the fatty acids do not
adversely affect the overall structure of the 8-kDa domain fragment.
Analysis of the Binding of Fatty Acids to the N-Terminal 8-kDa
Domain by NMR--
The NMR structures of the N-terminal 8-kDa domain
have recently been determined by Wilson, Mullen, and their co-workers
(19). According to their results, the 8-kDa domain (residues 1-87) is formed by four
In studying the effects of fatty acid binding, the recombinant 8-kDa
domain fragment was titrated with a 12.5 mM stock solution of LA or NA. Two-dimensional 1H-15N HMQC
spectra were recorded for the 8-kDa domain-fatty acid complex at fatty
acid concentrations of 0.3125, 0.625, 0.9375, 1.25, 1.5625, 1.875, 2.1875, and 2.5 mM. The complex is in fast exchange on the
time scale of NMR, permitting us to follow the chemical shift changes
of the backbone NH and 15N signals of the 8-kDa domain upon
complex formation by recording a series of
1H-15N HMQC spectra of uniformly
15N-labeled 8-kDa domain in the presence of increasing
amounts of fatty acids. Of the 79 amides in residues 5-86 of the 8-kDa
domain, 75 amides were assigned in the fatty acid complex. The
cross-peak for Leu-11 was sufficiently resolved during the titration to
allow determination of the mole fraction of protein bound with fatty acids. The backbone amide of Leu-11 displays the longest chemical shift
change upon complexation. The change in the chemical shift of the
Leu-11 resonance is interpreted as resulting from the chemical shifts
for the free ( Mapping of the Fatty Acid Interaction Interface--
Fig.
6A shows the residues
displaying chemical shift changes on binding to the fatty acids in the
solution structure of the 8-kDa domain with or without fatty acids. NH
chemical shift changes of 0.015-0.03 ppm and 15N chemical
shift changes of 0.1-0.2 ppm (Lys-5, Leu-22, Ala-23, Asn-28, Asn-37,
Tyr-39, Lys-52, Ile-73, Asp-74, Ala-78, Leu-82, and Lys-84) are shown
in yellow. NH chemical shift changes of 0.03-0.06 ppm and
15N chemical shift changes of 0.2-0.4 ppm (Ala-6, Gln-8,
Glu-9, Glu-26, Val-29, Ser-30, Ile-33, Phe-76, Leu-77, and Gly-80) are shown in orange. NH chemical shift changes of more than 0.06 ppm and 15N chemical shift changes of more than 0.4 ppm
(Leu-11, Lys-35, His-51, and Thr-79) are shown in red. These
exposed residues showing significant changes were the same between LA
and NA (Figs. 4C and 5). In the presence of either LA or NA,
the cross-peaks were shifted as follows: Lys-5, Ala-6, Gln-8, Glu-9,
and Leu-11 were in the unstructured segment; Glu-26 was in helix-1,
which is adjacent to the
Fig. 6B shows the mapping in the solution structure of
the 8-kDa domain with ssDNA. The data determined by Wilson, Mullen, and
their co-workers, the NMR structures (16, 19) and the results of
site-directed mutagenesis of the 8-kDa domain (14), were used to
illustrate the map. According to Prasad et al. (14), the
site-directed mutants of Phe-25, Lys-35, Lys-60, or Lys-68 were
impaired template DNA binding activity. Since the fatty acids bind to
the ssDNA-binding region of the 8-kDa domain and compete for binding
with template DNA as shown in Fig. 1, two of the maps were compared. In
Fig. 6B, the residues (Gln-31, Asn-37, Arg-40, Lys-41,
Ala-57, Glu-58, Lys-60, Gly-66, Lys-68, Glu-71, Lys-72, Glu-75, Ala-78,
Leu-82, Arg-83, and Leu-85) of the p(dT)8 interaction interface from the HMQC NMR experiment (16) are shown. As shown in Fig.
6, A and B, the only site shifted not only by
fatty acid binding, but by ssDNA (i.e. p(dT)8)
binding was Lys-35 in the Modeling of the Fatty Acid Interaction Interface--
-To confirm
the above assumption, we performed modeling analysis using the results
of NMR experiments. The results of computer simulation of the binding
mode between the N-terminal 8-kDa domain and the fatty acids are shown
in Fig. 7. NA (yellow line) on
the 8-kDa domain (blue-white line) in Fig. 7, A
and B, was bridged from Lys-35 (red line) to
Leu-11 (red line), His-51 (red line), and Thr-79
(red line) and intercalated smoothly into the pocket between
helix-1 and helix-2 in the
In conclusion, the lack of an effect of shorter chain fatty acids, the
positive relationship between longer carbon chain length and tighter
binding, and the configuration effectiveness on pol
The inhibitory effects of fatty acids on DNA polymerase activity occur
by binding between the 8-kDa domain and the fatty acid as a 1:1
complex, and this binding can be released by nonionic detergents (2,
3). The fatty acids are present on the internal surface of the
cytoplasmic membranes. These observations suggest that the inhibitory
effect of fatty acids on DNA polymerase activity occurs in
vivo and is reversibly controlled by binding to or release of the
DNA polymerase from the fatty acids, perhaps on the membranes. These
observations may help in determining the mechanisms of control of these
enzymes in vivo.
We are grateful to Dr. A. Matsukage of Aichi
Cancer Center Research Institute for his advice and encouragement for
this work. We are also grateful to K. Suetsuna of Daikin Industry Ltd.
for the technical support of computer graphics. We thank Dr. H. Taguchi of our department for helpful discussion, and A. Ogawa, Y. Fukuyo, and
S. Tojo of our department for their helpful support.
*
This work partly was supported by the Sasakawa Scientific
Research Grant (to Y. M.) from The Japan Science Society.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed. Tel.: 81-471-24-1501. Fax: 81-471-23-9767; E-mail: kengo@rs.noda.sut.ac.jp
The abbreviations used are:
pol, DNA polymerase
(EC 2.7.7.7);
NA, nervonic acid;
LA, linoleic acid;
ssDNA, single
strand deoxyribonucleic acid;
HMQC, heteronuclear multiple-quantum
correlated spectroscopy;
PAGE, polyacrylamide gel
electrophoresis.
Mode Analysis of a Fatty Acid Molecule Binding to the N-terminal
8-kDa Domain of DNA Polymerase
A 1:1 COMPLEX AND BINDING SURFACE*
,
,
,
, and
**
Department of Applied Biological Science,
Science University of Tokyo, 2641 Yamazaki, Noda, Chiba 278-8510, Japan, the § Japan Advanced Institute of Science and
Technology, 15 Asahidai, Tatsunokuchi, Ishikawa 923-1292, Japan, the
¶ Department of Biochemistry, Kanazawa Medical University,
Uchinada, Kahoku-gun, Ishikawa 920-0293, Japan, and the
Department of Biological Science, Teikyo University of Science
and Technology, Yamanashi 409-0193, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
. At
present, based on information available from the NMR structure of the
N-terminal 8-kDa domain, we examined the structural interaction with
the 8-kDa domain using two species, C18-linoleic acid
(LA) or C24-nervonic acid (NA). In the 8-kDa domain with LA
or NA, the structure that forms the interaction interface included
helix-1, helix-2, helix-4, the three turns (residues 1-13, 48-51, and
79-87) and residues adjacent to an
-type loop connecting helix-1
and helix-2 of the same face. No significant shifts were observed for
any of the residues on the opposite side of the 8-kDa domain. The NA
interaction interface on the amino acid residues of the 8-kDa domain
fragment was mostly the same as that of LA, except that the shifted
cross-peaks of Leu-11 and Thr-79 were significantly changed between LA
and NA. The 8-kDa domain bound to LA or NA as a 1:1 complex with
a dissociation constant (KD) of 1.02 or 2.64 mM, respectively.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
(pol
)1 and DNA polymerase
(pol
) in vitro and plant DNA polymerases, albeit less
potently, but that at the concentrations used, the fatty acids hardly
influenced the activities of prokaryotic DNA polymerases or other DNA
metabolic enzymes such as DNase I (1, 2). The most potent inhibitors
were fatty acids, which have the following characteristics: hydrocarbon
chain containing 18 or more carbons, a free carboxyl end, and the
cis-configuration is preferred to the
trans-configuration. Fatty acids in the
trans-configuration have a much weaker inhibitory effect on
pol
, and those in which the carboxyl end is chemically modified can
lose the inhibitory effect on both pol
and pol
. The mode of
inhibition by longer chain fatty acids showed the same characteristics,
except that the minimum inhibitory doses of these longer chain fatty
acids were much lower (2, 3). Lineweaver-Burk plots of the fatty acids
indicated that both the substrate (i.e.
deoxynucleotide)-binding and the template DNA-binding sites of pol
were nonantagonistically inhibited by the fatty acids, but they were
effective as antagonists against the sites of pol
. For pol
,
fatty acids acted by competing with not only the substrate but also the
template-primer DNA. In screening inhibitors of eukaryotic DNA
polymerase, we also found several natural compounds which inhibited pol
in the same manner as fatty acids (4-10).
is the smallest known DNA polymerase in animal cells with a
molecular mass of 39 kDa, and its structure is highly conserved among
mammals (11). This protein has a modular two-domain structure, with
apparent flexibility within a protease-sensitive region between residues 82 and 86, which separates the two domains. Treatment with
trypsin yields an N-terminal domain fragment (8 kDa), which retains
binding affinity for single-stranded DNA (ssDNA), and a C-terminal
domain fragment (31 kDa) with reduced DNA polymerase activity (12, 13).
We reported previously the mode of biochemical inhibition by fatty
acids using two of the pol
fragments that were proteolytically
separated (3). The fatty acids were found to bind to the 8-kDa
DNA-binding domain fragment and to suppress binding to the
template-primer DNA. A 10,000-fold higher level of fatty acid was
required for binding to the 31-kDa catalytic domain or to inhibit the
DNA polymerase activity, suggesting that it directly disturbs the
template-primer incorporation into the template-primer-binding domain
and indirectly competes with the substrate on its binding site in the
catalytic domain (3). The binding between the enzymes and fatty acids
can be released by detergents without any permanent damage to the
structure (2, 3). These results suggested that the binding is
physiologically specific and has some roles in vivo: for
example, to maintain the enzymes in the inactive state on the internal
surface of the membranes. In this study, we analyzed the structural
interactions of C18 and C24 fatty acids with
pol
, especially the N-terminal 8-kDa domain, in cross-linking
studies using a 5'-end-labeled photoprobe (dT14D) instead
of template-primer DNA and the binding surface of the 8-kDa domain in
contact with the fatty acids by NMR.
and the N-terminal 8-kDa
domain of pol
have been determined recently by Wilson and his
co-workers (14-22). Based on the information available from their
studies of crystal and NMR analyses of pol
and the 8-kDa domain
(14-22), we compared the interaction interface for ssDNA template with
that for the fatty acids. The study of the relationship between fatty
acids and pol
may reveal why C16 or shorter fatty acids
cannot inhibit the polymerase activity (2), why the minimum inhibitory
doses of longer chain fatty acids are much lower than those of shorter
chain species, although the biochemical mode of inhibition is the same,
and how the fatty acids bind to the N-terminal 8-kDa domain. These
studies may help to further clarify the structure and function of pol
and subsequently may allow us to speculate on the in
vivo role of DNA polymerase inhibition by fatty acids.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
(residues 2-87) was overexpressed in Escherichia
coli strain BL21 harboring the expression plasmid "Lys-87"
constructed in our laboratory. Overproduction of the N-terminal 8-kDa
domain and the purification procedure have principally been described
in our previous report (23). For 15N-correlated NMR
experiments, the N-terminal 8-kDa domain was expressed from BL21/Lys-87
grown on minimal medium containing 15NH4Cl as
the sole nitrogen source (24). In preparing the NMR sample, the
purified N-terminal domain was concentrated using a Centricon-3
(Amicon) and exchanged into 5 mM potassium phosphate buffer
(pH 7.0) and 20% D2O. Two samples for NMR experiments
contained 1.25 mM 15N-labeled N-terminal 8-kDa
domain after addition of fatty acids (linoleic acid (LA) and nervonic
acid (NA)). The fatty acids (12.5 mM each) were dissolved
in Me2SO-d6. Fragments of 8 and 31 kDa of pol
were prepared and purified as described previously
(3).
with Photolabile dT14D--
The reaction mixture (9.4 µl) was comprised of 50 mM Tris-HCl (pH 8.8), 1 mM dithiothreitol, 100 mM KCl, 0.5 mM MnCl2, 0.085 µM
32P-5'-end-labeled photoprobes dT14D
(i.e. an oligothymidylate 15-mer analogue containing a
photolabile
2'-deoxy-E-5-[4-(3-trifluoromethyl-3H-diazirin-3-yl)styryl]uridylate residue at the 3' terminus, 0.8 pmol/reaction mixture) (25), and 20%
Me2SO with various concentrations of fatty acids. The 8-kDa
domain fragment (0.14 µg, 18 pmol) and 31-kDa domain (0.55 µg, 18 pmol) or 8-kDa domain fragment (0.14 µg, 18 pmol) were added in the
reaction mixture. Incubation was carried out for 5 min at 25 °C.
After chilling at 0 °C, the reaction mixture was irradiated with a
near-UV lamp as described (25) for 10 min in an ice bath. The product
was analyzed by SDS-PAGE (12.5% separation gel) (26) and detected by autoradiography.
and 62.5 µM fatty acid mixture (molecular ratio, enzyme:inhibitor = 1:10) were dissolved in 5 mM
potassium phosphate buffer (pH 7.0) containing 5% methanol. The
chromatograms for the mixtures were compared with that of the 8-kDa
domain alone. The concentrations of the proteins were determined by UV
adsorption at 280 nm (
280 = 5440 M
1 cm
1). CD measurements were
performed on a Jasco J-720 spectropolarimeter in a 1-cm cell at
25 °C. The CD spectra were collected from 260 to 200 nm at a
resolution of 1 nm using up to eight scans. The per residue molar
ellipticity (degree·cm2 dmol
1) was
calculated from the concentration for the 87-residue polypeptide.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
, and the fatty acids in which the carboxyl end is
chemically modified can lose the inhibitory effect. In this study, we
analyzed the structure of pol
and its relationship to the
long-chain fatty acids in more detail. Lineweaver-Burk plots of fatty
acids indicated that both the substrate-binding and the template
DNA-binding sites of pol
were antagonistically inhibited by fatty
acids (2, 3). We tested fatty acids from C18 to the longest
commercially available, C24, previously (3). Among the
fatty acids examined, the strongest inhibitor was a C24
fatty acid, nervonic acid (NA), and the weakest was a C18 fatty acid, linoleic acid (LA) (3). We therefore analyzed the mode of
binding to pol
using the longest and the shortest fatty acids in
the present study.
, which was also used in this study, can be divided into two
domain fragments (8- and 31-kDa polypeptides) using controlled proteolysis (12, 13). The 8-kDa domain is the DNA template-binding domain, and the 31-kDa domain is the catalytic part involved in DNA
polymerization. According to the methods described by Kumar et
al. (12), we purified both of these fragments by fast protein liquid chromatography Superose 12 (lanes 3 and 4 in Fig. 4, Ref. 3) and used them in this experiment. We also suggested
previously that the fatty acids bind to pol
and the 8-kDa domain
fragment, but not to the 31-kDa domain fragment (3). Both NA and LA
appear to interact with the enzyme or the 8-kDa domain fragment in the same way, but the longer chain binds to the domain fragment more tightly and inhibits DNA polymerase activity much more strongly.
by Using Cross-linking--
The labeling abilities
of the synthesized 32P 5'-end-labeled photoprobes
(dT14D) were investigated using the N-terminal 8-kDa and
C-terminal 31-kDa domain fragments of the recombinant rat pol
(39 kDa). The 32P 5'-end-labeled photoprobe (dT14D)
had a molecular mass of 5 kDa. dT14D was mixed with 8- and
31-kDa fragments of pol
and irradiated with near-UV light as
described under "Experimental Procedures," and then analyzed by gel
mobility shift assay (Fig. 1). As shown
in Fig. 1A, autoradiography of the radioactive products of the 8-kDa
domain fragment resolved by SDS-PAGE showed a shift from the original
8-kDa to the 13 (8 + 5)-kDa position as the labeled protein complex
(lane 1). Poly (dT), which is a DNA template, competed with
the photoprobe for binding to the 8-kDa domain fragment (lanes
1-3 in Fig. 1A). The 8-kDa band observed in Fig. 1A may have been
due to the absorption of very small amount of labeled photoprobe. A
small amount of dT14D could bind to the 31-kDa domain fragment and cause a shift to the 36 (31 + 5)-kDa position, although this band was faint (lane 1 in Fig. 1A). The
SDS-PAGE characteristics of dT14D and recombinant rat pol
(39 kDa) were shown previously (Fig. 6 of Ref. 25). When the
mixture was not irradiated, no cross-linking of the proteins with
dT14D was observed (lane 4 in Fig.
1A). The 8-kDa domain fragment of pol
could be shifted with the cross-linked dT14D, but the 31-kDa fragment, the
catalytic domain without a DNA-binding site, could not, because this
domain has no DNA binding capacity (lane 1 in Fig.
1A). Cross-linking of the fragments of pol
with
photolabile dT14D was inhibited by addition of the natural
template, poly(dT) (lanes 1-3 in Fig. 1A),
showing that the 8-kDa domain fragment has contained the template
DNA-binding site.

View larger version (20K):
[in a new window]
Fig. 1.
Photoaffinity cross-linking of the N-terminal
8-kDa or the C-terminal 31-kDa domain fragment of rat DNA
polymerase
with 32P-5'-end-labeled photolabile
dT14D. The photoaffinity cross-linking experiments
were carried out as described under "Experimental Procedures." The
concentration of photolabile dT14D used was 0.8 pmol in
each lane. A, the 8- and 31-kDa fragments were added at 18 pmol. The concentrations of poly(dT) are described in each panel.
B and C, in the presence of 18 pmol of 8-kDa
fragment and 0.8 pmol of dT14D, LA (B), or NA
(C) was added at the concentration indicated in each
panel.
activity by
NA was 10-fold stronger than that by LA although the biochemical mode
of inhibition was the same (2, 3).

View larger version (17K):
[in a new window]
Fig. 2.
. CD spectra of the N-terminal 8-kDa domain of
DNA polymerase
with the fatty acids. The
CD spectra were collected as described under "Experimental
Procedures." Black line, the 8-kDa domain only;
dotted line, the mixture of the 8-kDa domain and LA;
gray line, the mixture of the 8-kDa domain and NA.
-helices, packed as two antiparallel pairs. The pairs
of
-helices cross one another at 50° giving them a V-like shape.
The 8-kDa domain contains a motif termed the "helix-hairpin-helix." The protein residues involved in template DNA binding have been identified by NMR using chemical shift changes (16). The
helix-3-hairpin-helix-4 motif and residues in an adjacent
-type loop
connecting helix-1 and helix-2 form the ssDNA interaction surface (16).
Furthermore, they also found that several mutants of the 8-kDa domain
(F25W, K35A, K60A, and K68A) showed impaired template DNA binding
activity (14). In a biochemical study, using the purified recombinant 8-kDa domain, photochemical cross-linking studies showed that residues
Ser-30 and His-34 cross-linked to p(dT)16 (27).
F) and the bound forms (
B) of the Leu-11 resonance
being averaged into a single resonance (
av) (i.e.
(
F
B)
koff for the complex
(28)). Fitting of the titration curve for the amide proton resonance of
Leu-11 indicated that the 8-kDa domain binds to LA or NA as a 1:1
complex with a KD of 1.02 or 2.64 mM,
respectively (Fig. 3), indicating that
the longer fatty acid could bind to the fragment more tightly. This
probably explains why the minimum inhibitory dose of the longer chain
fatty acid was much lower, although the biochemical mode of inhibition was the same. Since C16 or shorter fatty acids are expected
to have higher KD values than the
KD of the C18 fatty acid, this may also
explain why the shorter chain fatty acids cannot inhibit polymerase
activity. Fig. 4A shows the
1H-15N HMQC spectrum of the 8-kDa domain alone.
Fig. 4B shows the 1H-15N HMQC
spectrum of the 8-kDa domain (blue contours) overlaid on that of the 1:1 mixture of the 8-kDa domain and NA (red
contours). Similarly, Fig. 4C depicts the superimposed
spectra of the 1:1 mixture of the 8-kDa domain and NA (red
contours) and the 1:1 mixture of the 8-kDa domain and LA
(green contours). Chemical shift changes of
0.015 for
1H and
0.1 for 15N were determined for Lys-5,
Ala-6, Gln-8, Glu-9, Leu-11, Leu-22, Ala-23, Glu-26, Asn-28, Val-29,
Ser-30, Ile-33, Lys-35, Asn-37, Tyr-39, His-51, Lys-52, Ile-73, Asp-74,
Phe-76, Leu-77, Ala-78, Thr-79, Gly-80, Leu-82, and Lys-84 (Fig.
5). The data in Fig. 5 indicate the NH
chemical shift differences in the presence of 1.25 mM LA or NA along the amino acid sequence of the 8-kDa
domain in Fig. 4. The shifted cross-peaks for LA were the same as those for NA, except Leu-11 and Thr-79, suggesting that the mode of binding
to the domain does not change between LA and NA.

View larger version (15K):
[in a new window]
Fig. 3.
Determination of KD
for fatty acid binding to the N-terminal 8-kDa domain of DNA
polymerase
(1.25 mM). Titration of LA or NA was performed to
measure the chemical shift change at the nondegenerate Leu-11 amide
proton in 1H-15N HMQC NMR. The
KD values of LA and NA were 1.02 and 2.64 mM, respectively.


View larger version (30K):
[in a new window]
Fig. 4.
Expanded 1H-15N HMQC
spectra of the 15N-labeled N-terminal 8-kDa domain-fatty
acid complex. A, the N-terminal 8-kDa domain (1.25 mM) only. The values in the figure indicate the amino acid
sequences of the 8-kDa domain peptide. B, the N-terminal
8-kDa domain (1.25 mM) in the absence (blue) or
presence (red) of 1.25 mM NA. C, the
N-terminal 8-kDa domain (1.25 mM) in the presence of 1.25 mM LA (green) or NA (red). In
B and C, the major shifted cross-peaks of the
amino acid residues are indicated as the amino acid sequence.

View larger version (24K):
[in a new window]
Fig. 5.
Chemical shift changes for the N-terminal
8-kDa domain of DNA polymerase
on complex
formation with the fatty acids LA and NA. The chemical shift
differences (the cross-peak shift values of the free domain minus those
of the domain complex shown in Fig. 4) for the amide proton chemical
shifts (A) or for the amide 15N chemical shifts
(B) are shown in bars.
-type loop; Asn-28, Val-29, Ser-30, Ile-33,
and Lys-35 were in the
-type loop; Asn-37 and Tyr-39 were in
helix-2, which is adjacent to the
-type loop; His-51 and Lys-52 were
in a turn; Ile-73, Asp-74, Phe-76, Leu-77, and Ala-78 were in helix-4,
which is adjacent to the 48-55 turn and 79-87 unstructured linker
segment; Thr-79, Gly-80, Leu-82, and Lys-84 were in the unstructured
linker segment that connects to the 31-kDa catalytic domain in the
full-length enzyme. These chemical shift changes can be explained in
terms of the fatty acid contact and perturbation in the electrostatic charge distribution at the surface. Surface residues displaying chemical shift changes were predominantly, although not entirely, clustered on one side of the domain (Fig. 6A). Furthermore,
the fatty acid-binding interface of the 8-kDa domain consists of two regions: one consisting of Leu-11 in the 1-13 unstructured segment, His-51 in the 45-55 turn, and Thr-79 in the 79-87 unstructured linker
segment ("I" in Fig. 6A), while the other
consists of an
-type loop, including helix-1 and helix-2
("II" in Fig. 6A).

View larger version (14K):
[in a new window]
Fig. 6.
Interaction between the fatty acid and the
amino acid residues of the N-terminal 8-kDa domain of rat DNA
polymerase
(Protien Data Base code
1BNO). The N-terminal domain consists of four helices, helix-1
(15-26), helix-2 (36-47), helix-3 (56-61), and helix-4 (69-78),
tightly packed to form a hydrophobic core. The remainder of the domain
consists of two turns (48-55 and 62-68), an
-type loop (27-35),
and extended structures (1-14 and 79-87). A, interactions
between fatty acids and the 8-kDa domain. The amino acid residues of
the major shifted cross-peaks from HMQC NMR experiments are indicated.
0.015-0.03 ppm of NH chemical shift changes and 0.1-0.2 ppm of
15N chemical shift changes are depicted in
yellow. 0.03-0.06 ppm of NH chemical shift changes and
0.2-0.4 ppm of 15N chemical shift changes are indicated in
orange. NH chemical shift changes at more than 0.06 ppm and
15N chemical shift changes at more than 0.4 ppm are
indicated in red. B, interactions between ssDNA
and the 8-kDa domain. These data were from the experiments reported by
Wilson, Mullen, and their co-workers (14, 16, 19). The amino acid
residues Phe-25, Lys-35, Lys-60, and Lys-68, which were shown to be
necessary for ssDNA binding activity by site-directed mutagenesis (14),
are indicated in blue. The amino acid residues of the major
shifted cross-peaks from HMQC NMR experiments (16) are depicted in
pink.
-type loop including helix-1 and helix-2.
The region II shown in Fig. 6A appears to have an important
role in the fatty acid effect. The fatty acids probably compete with
template DNA at the residue Lys-35 and bind to the site, which
subsequently inhibits the ssDNA binding activity on the 8-kDa domain.
In the region I shown in Fig. 6A, Leu-11, His-51, and Thr-79
are different from the other DNA binding sites (Phe-25, Lys-60, and
Lys-68), suggesting that the methyl end of fatty acids disturb the
binding of the template DNA at region I. Lys-35 in region II is a
hydrophilic amino acid, and Leu-11 and His-51 in region I are
hydrophobic amino acids. The carboxyl ends of the fatty acids may,
therefore, show a preference for binding to the hydrophilic site, and
the other side, the methyl end, may be absorbed to the hydrophobic site. We reported previously (2, 3) that longer chain fatty acids
inhibited the binding activity more strongly and that C16 or shorter fatty acids have no inhibitory effect. The distance between
regions I and II may be a key to explain these characteristics of the
inhibition by fatty acids. As shown in Figs. 3, 4C, and 5,
the shifted cross-peaks of Leu-11 and Thr-79 were significantly changed
between LA and NA. The longer chain fatty acids (over C24)
are expected to more tightly bind to these residues of amino acids in
the 8-kDa domain.
-type loop. The distance between the
Lys-35 hydrophilic region and Leu-11 and His-51 hydrophobic regions fit
the length of U-shaped NA. On the other hand, LA (yellow line) was trapped more deeply in the pocket, although the LA
binding model is basically the same as that of NA, and was further away from regions I and II than in the NA binding model (Fig. 7,
C and D). The methyl end of LA may not be able to
bind firmly to region I, and subsequently, a steeper U-shaped model was
postulated for LA (Fig. 7, C and D). In this
simulation, the fatty acid structures were modeled, but the 8-kDa
domain structure was fixed. Although the residues shown by red
lines seemed to be separated from the fatty acid structures
(yellow lines) (Fig. 7), the fatty acid ends are thought to
bind to the respective amino acid residues, and at least the Lys-35
binding area in the 8-kDa domain peptide must be strained. The
unstructured segment of the 1-13 turn is comprised of the N-terminal
residues and is flexible. The 79-87 turn, i.e. the
unstructured linker segment, must also be structurally flexible.
Therefore, when the fatty acids bound to the domain at His-51 and
Lys-35, the N-terminal turn including Leu-11 and the unstructured
linker segment including Thr-79 appear to be adjacent to His-51 in the
45-55 turn. The longer chain fatty acids, since they can more likely
gain access to region I, can affect the tighter binding to region I. LA
or shorter fatty acids are located at some distance from the site and
may hardly induce the movement. We also reported previously that the
saturated forms of fatty acids, for example C18-stearic
acid, had no inhibitory effect on pol
, although then could suppress
the activity of pol
(2). The carbon chain in the saturated form
fatty acid molecule is linear and does not form a U-shaped curve as
seen in the unsaturated form fatty acids such as LA and NA. The linear chain may not be able to intercalate between helix-1 and helix-2 in the
-type loop and thus cannot inhibit pol
activity.

View larger version (116K):
[in a new window]
Fig. 7.
Simulation of the fatty acid interaction
interface on the N-terminal 8-kDa domain of rat DNA polymerase
(Protein Data Base code 1BNO). Interactions
between the 8-kDa domain and NA (A and B) or LA
(C and D) are shown. The x-ray crystal structure
of the N-terminal 8-kDa domain of pol
is shown in
blue-white. The amino acid residues Leu-11, Lys-35, His-51,
and Thr-79, which were significantly shifted as the cross-peaks from
HMQC NMR experiments, are depicted in red. The fatty acids
are indicated in yellow. This figure was displayed using Mol
Graph (Daikin Industry Ltd.).
can be
explained by our model.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Mizushina, Y.,
Yagi, H.,
Tanaka, N.,
Kurosawa, T.,
Seto, H.,
Katsumi, K.,
Onoue, M.,
Ishida, H.,
Iseki, A.,
Nara, T.,
Morohashi, K.,
Horie, T.,
Onomura, Y.,
Narusawa, M.,
Aoyagi, N.,
Takami, K.,
Yamaoka, M.,
Inoue, Y.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1996)
J. Antibiot. (Tokyo)
49,
491-492[Medline]
[Order article via Infotrieve]
2.
Mizushina, Y.,
Tanaka, N.,
Yagi, H.,
Kurosawa, T.,
Onoue, M.,
Seto, H.,
Horie, T.,
Aoyagi, N.,
Yamaoka, M.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1996)
Biochim. Biophys. Acta
1308,
256-262[Medline]
[Order article via Infotrieve]
3.
Mizushina, Y.,
Yoshida, S.,
Matsukage, A.,
and Sakaguchi, K.
(1997)
Biochim. Biophys. Acta
1336,
509-521[Medline]
[Order article via Infotrieve]
4.
Ohta, K.,
Mizushina, Y.,
Hirata, N.,
Takemura, M.,
Sugawara, F.,
Matsukage, A.,
and Sakaguchi, K.
(1999)
Biol. Pharm. Bull.
22,
111-116[Medline]
[Order article via Infotrieve]
5.
Mizushina, Y.,
Tanaka, N.,
Kitamura, A.,
Tamai, K.,
Ikeda, M.,
Takemura, M.,
Sugawara, F.,
Arai, T.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1998)
Biochem. J.
330,
1325-1332
6.
Mizushina, Y.,
Watanabe, I.,
Ohta, K.,
Takemura, M.,
Sahara, H.,
Takahashi, N.,
Gasa, S.,
Sugawara, F.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1998)
Biochem. Pharmacol.
55,
537-541[CrossRef][Medline]
[Order article via Infotrieve]
7.
Togashi, H.,
Mizushina, Y.,
Takemura, M.,
Sugawara, F.,
Koshino, H.,
Esumi, Y.,
Uzawa, J.,
Kumagai, H.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1998)
Biochem. Pharmacol.
56,
583-590[CrossRef][Medline]
[Order article via Infotrieve]
8.
Mizushina, Y.,
Watanabe, I.,
Togashi, H.,
Hanashima, L.,
Takemura, M.,
Ohta, K.,
Sugawara, F.,
Koshino, H.,
Esumi, Y.,
Uzawa, J.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1998)
Biol. Pharm. Bull.
21,
444-448[Medline]
[Order article via Infotrieve]
9.
Ohta, K.,
Mizushina, Y.,
Hirata, N.,
Takemura, M.,
Sugawara, F.,
Matsukage, A.,
Yoshida, S.,
and Sakaguchi, K.
(1998)
Chem. Pharm. Bull.
46,
684-686
10.
Tanaka, N.,
Kitamura, A.,
Mizushina, Y.,
Sugawara, F.,
and Sakaguchi, K.
(1998)
J. Nat. Prod.
61,
193-196[CrossRef][Medline]
[Order article via Infotrieve]
11.
Kornberg, A.,
and Baker, T.
(1992)
DNA Replication
, 2nd Ed.
, pp. 197-225, W. H. Freeman and Co., NY
12.
Kumar, A.,
Widen, S. G.,
Williams, K. R.,
Kedar, P.,
Karpel, R. L.,
and Wilson, S. H.
(1990)
J. Biol. Chem.
265,
2124-2131 13.
Kumar, A.,
Abbotts, J.,
Karawya, E. M.,
and Wilson, S. H.
(1990)
Biochemistry
29,
7156-7159[CrossRef][Medline]
[Order article via Infotrieve]
14.
Prasad, R.,
Beard, W. A.,
Chyan, J. Y.,
Maciejewski, M. W.,
Mullen, G. P.,
and Wilson, S. H.
(1998)
J. Biol. Chem.
273,
11121-11126 15.
Sawaya, M. R.,
Prasad, R.,
Wilson, S. H.,
Kraut, J.,
and Pelletier, H.
(1997)
Biochemistry
36,
11205-11215[CrossRef][Medline]
[Order article via Infotrieve]
16.
Liu, D.,
Prasad, R.,
Wilson, S. H.,
DeRose, E. F.,
and Mullen, G. P.
(1996)
Biochemistry
35,
6188-6200[CrossRef][Medline]
[Order article via Infotrieve]
17.
Pelletier, H.,
Sawaya, M. R.,
Wolfle, W.,
Wilson, S. H.,
and Kraut, J.
(1996)
Biochemistry
35,
12742-12761[CrossRef][Medline]
[Order article via Infotrieve]
18.
Pelletier, H.,
Sawaya, M. R.,
Wolfle, W.,
Wilson, S. H.,
and Kraut, J.
(1996)
Biochemistry
35,
12762-12777[CrossRef][Medline]
[Order article via Infotrieve]
19.
Liu, D.,
DeRose, E. F.,
Prasad, R.,
Wilson, S. H.,
and Mullen, G. P.
(1994)
Biochemistry
33,
9537-9545[CrossRef][Medline]
[Order article via Infotrieve]
20.
Davies, J. F., II,
Almassy, R. J.,
Hostomska, Z.,
Ferre, R. A.,
and Hostomsky, Z.
(1994)
Cell
76,
1123-1133[CrossRef][Medline]
[Order article via Infotrieve]
21.
Pelletier, H.,
Sawaya, M. R.,
Kumar, A.,
Wilson, S. H.,
and Kraut, J.
(1994)
Science
264,
1891-1903 22.
Sawaya, M. R.,
Pelletier, H.,
Kumar, A.,
Wilson, S. H.,
and Kraut, J.
(1994)
Science
264,
1930-1935 23.
Date, T.,
Yamaguchi, M.,
Hirose, F.,
Nishimoto, Y.,
Tanihara, K.,
and Matsukage, A.
(1988)
Biochemistry
27,
2983-2990[CrossRef][Medline]
[Order article via Infotrieve]
24.
Weber, D. J.,
Gittis, A. G.,
Mullen, G. P.,
Abeygunawardana, C.,
Lattman, E. E.,
and Mildvan, A. S.
(1992)
Proteins Struct. Funct. Genet.
13,
275-287
[CrossRef][Medline]
[Order article via Infotrieve] 25.
Yamaguchi, T.,
Suyama, K.,
Narita, K.,
Kohgo, S.,
Tomikawa, A.,
and Saneyoshi, M.
(1997)
Nucleic Acids Res.
25,
2352-2358 26.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
27.
Prasad, R.,
Kumar, A.,
Widen, S. G.,
Casas-Finet, J. R.,
and Wilson, S. H.
(1993)
J. Biol. Chem.
268,
22746-22755 28.
Raftery, M. A.,
Dahlquist, F. W.,
Chan, S. I.,
and Parsons, S. M.
(1968)
J. Biol. Chem.
243,
4175-4180
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-Y. Hu, J. K. Horton, M. R. Gryk, R. Prasad, J. M. Naron, D.-A. Sun, S. M. Hecht, S. H. Wilson, and G. P. Mullen Identification of Small Molecule Synthetic Inhibitors of DNA Polymerase {beta} by NMR Chemical Shift Mapping J. Biol. Chem., September 17, 2004; 279(38): 39736 - 39744. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mizushina, C. Murakami, H. Takikawa, N. Kasai, X. Xu, K. Mori, M. Oshige, T. Yamaguchi, M. Saneyoshi, N. Shimazaki, et al. Molecular Action Mode of Hippospongic Acid A, an Inhibitor of Gastrulation of Starfish Embryos J. Biochem., April 1, 2003; 133(4): 541 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kimura, Y. Uchiyama, N. Kasai, S. Namekawa, A. Saotome, T. Ueda, T. Ando, T. Ishibashi, M. Oshige, T. Furukawa, et al. A novel DNA polymerase homologous to Escherichia coli DNA polymerase I from a higher plant, rice (Oryza sativa L.) Nucleic Acids Res., April 1, 2002; 30(7): 1585 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mizushina, S. Kamisuki, N. Kasai, N. Shimazaki, M. Takemura, H. Asahara, S. Linn, S. Yoshida, A. Matsukage, O. Koiwai, et al. A Plant Phytotoxin, Solanapyrone A, Is an Inhibitor of DNA Polymerase beta and lambda J. Biol. Chem., January 4, 2002; 277(1): 630 - 638. [Abstract] [Full Text] |
||||
![]() |
Y. Mizushina, S. Kamisuki, T. Mizuno, M. Takemura, H. Asahara, S. Linn, T. Yamaguchi, A. Matsukage, F. Hanaoka, S. Yoshida, et al. Dehydroaltenusin, a Mammalian DNA Polymerase alpha Inhibitor J. Biol. Chem., October 20, 2000; 275(43): 33957 - 33961. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||